Home›Search›Current Neuropharmacology

Current Neuropharmacology

Bentham Science Publishers · United Arab Emirates · Est. 1969

ISSN1875-6190

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q1+25

Total60

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

1.555

H-Index

138

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

1.357

Total Works

2,201

Total Citations

92,670

2yr Mean Citedness

2.56

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on neuropharmacology, investigating the mechanisms and therapeutic potential of various agents and interventions for neurological and psychiatric disorders. Research includes the study of immunotherapies for neurodegenerative diseases like Alzheimer's, the effects of neuromodulation techniques such as transcranial magnetic stimulation, and the impact of substances like nitrous oxide and nicotine on brain function. The journal also covers the role of inflammation in drug metabolism for psychiatric conditions, the neuroprotective properties of compounds like glucagon-like peptide-1 receptor agonists, and the potential of traditional medicines and novel compounds in treating conditions such as stroke, epilepsy, and depression. Investigations into genetic and epigenetic factors influencing disease, as well as the role of glial cells and mitochondrial function in neurodegeneration, are also featured.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 25% in field

General Information

Country / RegionUnited Arab Emirates

Primary LanguageEnglish

1st Year Published1969

FrequencyMonthly, 2019-

StatusActive (last: 2026)

Total Publications2,201

Publisher OrgBentham Science Publishers

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Bentham Science Publishers

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1875-6190

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q1

NeurologyQ1

Neurology (clinical)Q1

PharmacologyQ1

Pharmacology (medical)Q1

Psychiatry and Mental HealthQ1

Subject Classification

Web of Science Categories

NeurosciencesPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Neurology (clinical)Psychiatry and Mental HealthMedicine (miscellaneous)Neurology

Research Topics (OpenAlex)

Neuroscience and Neuropharmacology ResearchTryptophan and brain disordersNeurotransmitter Receptor Influence on BehaviorAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsCholinesterase and Neurodegenerative DiseasesStress Responses and CortisolTreatment of Major DepressionParkinson's Disease Mechanisms and TreatmentsDiverse Scientific and Economic Studies